AnalystsRudy Li
Rudy Li's Stock Forecasts

Analyst Ranking
Top 2%
#91 out of 5254 analysts
Average Return
+112.58%
Win Rate
82%31 out of 38
Risk vs Reward
Poor
Good

Rudy Li's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+799.19%$38.09$342.50
2025-05-07 -
2026-04-17
Strong Buy
Alto Neuroscience IncANRO
+591.27%$4.01$27.72
2025-09-29 -
2026-04-17
Strong Buy
Praxis Precision Medicines IncPRAX
+512.04%$55.96$342.50
2025-07-29 -
2026-04-17
Strong Buy
Stoke Therapeutics IncSTOK
+275.54%$8.26$31.02
2025-03-19 -
2026-03-18
Strong Buy
Definium Therapeutics IncDFTX
+268.78%$6.15$22.68
2025-05-09 -
2026-04-17
Strong Buy

Rudy Li's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Centessa Pharmaceuticals PLCCNTA
5Buy$40.00+0.86%Initiates Coverage On
2 months ago
Alkermes PLCALKS
1Buy$45.00+30.32%Initiates Coverage On
2 months ago
Axsome Therapeutics IncAXSM
1Buy$230.00+21.70%Initiates Coverage On
2 months ago
Xenon Pharmaceuticals IncXENE
5Buy$60.00+0.50%Initiates Coverage On
2 months ago
Stoke Therapeutics IncSTOK
5Buy$40.00+7.32%Initiates Coverage On
2 months ago
Praxis Precision Medicines IncPRAX
4Buy$500.00+45.99%Initiates Coverage On
2 months ago
Neurocrine Biosciences IncNBIX
1Buy$160.00+20.08%Initiates Coverage On
2 months ago
Definium Therapeutics IncDFTX
5Buy$25.00+10.23%Initiates Coverage On
2 months ago
Acadia Pharmaceuticals IncACAD
1Buy$33.00+48.85%Initiates Coverage On
2 months ago
Bright Minds Biosciences IncDRUG
3Strong Buy$80.00N/AMaintains
4 months ago
Immunic IncIMUX
1Strong Buy$3.00+200.00%Initiates Coverage On
7 months ago
Alto Neuroscience IncANRO
1Strong Buy$15.00-45.89%Initiates Coverage On
7 months ago
Reviva Pharmaceuticals Holdings IncRVPH
1Strong Buy$40.00+4,605.88%Initiates Coverage On
7 months ago
Prothena Corp Public Ltd CoPRTA
7Strong Buy$18.00+65.14%Maintains
8 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.